VeriTeQ is a developer and marketer of innovative RFID technologies for implantable medical device identification and radiation dosimeters for use in cancer treatment. Our unique technology is used as a direct mark by medical device companies to identify implantable medical devices, in vivo, on demand, at the point of use, from outside the body. This technology is being used to help medical device manufacturers comply with the FDA’s Unique Device Identification (UDI) legislation. Specific examples include manufacturers of breast implants, vascular ports, pacemakers, as well as hip/knee/shoulder and spine replacements. VeriTeQ’s radiation dosimeters (both wearable and implantable) help radiation oncologists, therapists and physicists know the exact dosage of radiation penetrating a patient at the skin level and at the site of a tumor or tumor area. These medical devices provide cancer specialists with an excellent tool to help ensure patient safety and improve the overall quality of care.

Show more
Type
Public
HQ
Boca Raton, US
Founded
2011
Size (employees)
11 (est)
VeriTeQ Corporation was founded in 2011 and is headquartered in Boca Raton, US
Report incorrect company information

VeriTeQ Corporation Office Locations

VeriTeQ Corporation has an office in Boca Raton
Boca Raton, US (HQ)
19 6560 W Rogers Cir
Show all (1)
Report incorrect company information

VeriTeQ Corporation Financials and Metrics

VeriTeQ Corporation Financials

VeriTeQ Corporation's revenue was reported to be $151 k in FY, 2014 which is a 738.9% increase from the previous period.
USD

Revenue (Q3, 2016)

1.5 m

Net income (Q3, 2016)

(2.7 m)

EBIT (Q3, 2016)

(149.2 k)

Market capitalization (26-Oct-2017)

90.5 k

Closing share price (26-Oct-2017)

0.1
VeriTeQ Corporation's current market capitalization is $90.5 k.
Annual
USDFY, 2013FY, 2014FY, 2015

Revenue

18 k151 k

Revenue growth, %

739%

Cost of goods sold

7 k

Gross profit

11 k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

74 k21 k44 k95 k188 k4 k1.8 m1.5 m

Cost of goods sold

38 k8 k

Gross profit

36 k13 k

Gross profit Margin, %

49%62%
Annual
USDFY, 2013FY, 2014FY, 2015

Cash

13 k77 k

Accounts Receivable

11 k

Inventories

21 k2 k

Current Assets

1.2 m186 k12 k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

130 k2 k110 k24 k16 k2 k3 k1 k58.1 k

Accounts Receivable

168 k10 k20 k24 k60 k66 k116.5 k9.6 k

Inventories

3 k26 k16 k17 k242.6 k216.6 k

Current Assets

515 k1 m251 k130 k157 k113 k27 k7 k418.3 k232.1 k
Annual
USDFY, 2013FY, 2014FY, 2015

Net Income

(15.1 m)(3.9 m)(11.1 m)

Depreciation and Amortization

595 k

Accounts Payable

2.9 m

Cash From Operating Activities

(2 m)(2.6 m)(1.2 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(5.5 m)3.6 m(5.6 m)(893 k)(809 k)(3.4 m)(435.9 k)(3.1 m)

Depreciation and Amortization

149 k149 k149 k150 k47 k14.4 k21.7 k

Inventories

59.3 k85.3 k

Accounts Payable

94 k104 k103.9 k
USDY, 2016

Financial Leverage

-0.1 x
Show all financial metrics
Report incorrect company information